Abstract Aims/hypothesis A protective role of sodiumglucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic retinopathy and diabetic macular oedema has been described in some recent studies, which may extend beyond glycaemic control
After Your Treatment: Drink plenty of water to support nutrient distribution throughout your body
These associations remained consistent across subgroup analyses, including patients using tirzepatide as adjunctive therapy to other first-line diabetes agents, among patients older than 60 and comparisons against individual GLP-1 drugs, including semaglutide and dulaglutide
Why patients should care Many patients assume that if a product is being sold by someone in scrubs, promoted on Instagram, or injected in a clinic setting, it must automatically be safe or approved
Use features like bookmarks, note taking and highlighting while reading Life After The Shot: The Hidden Psychology of GLP-1 Success: Navigating Identity, Relationships, and Mental Space After GLP-1 Weight Loss When Food Noise
-